Exscientia PLC
NASDAQ:EXAI

Watchlist Manager
Exscientia PLC Logo
Exscientia PLC
NASDAQ:EXAI
Watchlist
Price: 4.84 USD Market Closed
Market Cap: 625.6m USD

Wall Street
Price Targets

EXAI Price Targets Summary
Exscientia PLC

There are no price targets for EXAI.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Exscientia PLC Competitors:
Price Targets
688192
Dizal Jiangsu Pharmaceutical Co Ltd
16% Upside
CPRX
Catalyst Pharmaceuticals Inc
59% Upside
MSB
Mesoblast Ltd
79% Upside
6990
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
5% Downside
BIOPOR
Bioporto A/S
181% Upside
VIR
Vir Biotechnology Inc
264% Upside
688382
InventisBio Co Ltd
18% Downside
SKYE
Skye Bioscience Inc
327% Upside

Revenue
Forecast

Revenue Estimate
Exscientia PLC

For the last 3 years the compound annual growth rate for Exscientia PLC's revenue is 17%. The projected CAGR for the next 3 years is 32%.

17%
Past Growth
32%
Estimated Growth
Estimates Accuracy
-23%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Exscientia PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
16%
Average Beat

Net Income
Forecast

Net Income Estimate
Exscientia PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is EXAI's stock price target?
Not Available

EXAI doesn't have any price targets made by Wall Street professionals.

What is Exscientia PLC's Revenue forecast?
Projected CAGR
32%

For the last 3 years the compound annual growth rate for Exscientia PLC's revenue is 17%. The projected CAGR for the next 3 years is 32%.

Back to Top